Browsing: FDA approval

FDA approves daraxonrasib, the first targeted pill for advanced pancreatic cancer, offering patients longer survival and fewer side effects.

FDA approval positions Wockhardt’s Zaynich in the $9 billion antibiotics market, expanding into drug-resistant bacterial infections.

Gilead to acquire Arcellx for $7.8 billion, strengthening oncology pipeline with anito-cel CAR T-cell therapy.